Compared with insulin, GLP-1 use during pregnancy didnt increase the risk of major birth or heart defects
Approved by the FDA for type 2 diabetes management, Tirzepatide continues to undergo rigorous research for potential weight loss applications in non-diabetic patients
Authors relationships and activities JSN reports having received consulting and speaker fees from AstraZeneca, BIAL, Boehringer Ingelheim, Eli Lilly and Novo Nordisk and speaker fees from Merck
Like Ozempic, Rybelsus is FDA-approved for the treatment of type 2 diabetes, not for weight loss
Sort of just found my passion and the answers I had been looking for with this new specialty finally after years of treating people with the Band-Aid fix it when its broken mentality instead of at the root cause. Mike has spent the last 10 years in Anti-Aging, Functional and Regenerative Medicine
Nationwide Shipping & Compliance Assurance Serving clinics, hospitals, and wellness centers